AMI
Clinical trials for AMI explained in plain language.
Never miss a new study
Get alerted when new AMI trials appear
Sign up with your email to follow new studies for AMI, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a diabetes pill mend broken hearts after a heart attack?
Disease control Recruiting nowThis study tests whether dapagliflozin, a drug already used for diabetes and heart failure, can help the heart recover after a heart attack. About 450 adults who have had a heart attack and have weak heart pumping will receive either the drug or a placebo for 6 months. The goal i…
Matched conditions: AMI
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 26, 2026 05:23 UTC
-
Oxygen boost after heart attack: could it save more heart muscle?
Disease control Recruiting nowThis study tracks 1,000 adults who had a major heart attack to see if adding SuperSaturated Oxygen therapy to standard artery-opening treatment reduces heart damage and prevents future heart problems. Participants are either given the extra oxygen or standard care alone, and rese…
Matched conditions: AMI
Sponsor: TherOx • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
New drug aims to limit heart damage after attack
Disease control Recruiting nowThis study tests a medicine called Xolatryp in adults who have had a severe type of heart attack (STEMI) and are getting a procedure to open the blocked artery. Participants receive either Xolatryp or a placebo as a one-time IV infusion over 6 hours. The study checks if the drug …
Matched conditions: AMI
Phase: PHASE2 • Sponsor: Nyrada Pty Ltd • Aim: Disease control
Last updated May 18, 2026 12:12 UTC